Rousselot® Biomedical launches Quali-Pure™, a range of gelatins with controlled purity, supporting full compliance with new EU Medical Device Regulations and ISO 22442

Rousselot®, the Health brand of Darling Ingredients and the global leader of collagen-based solutions launches Quali-Pure™, a range of gelatins for biomedical applications with controlled endotoxin levels. The latest addition to Rousselot Biomedical’s rapidly expanding portfolio, Quali-Pure, has been specifically designed for a variety of applications including embolization, wound healing, drug delivery, vaccines and hemostatics.

Genesis Research Announces Significant Enhancements to EVID AI, the World’s Largest AI-Enabled Healthcare Literature Database for Faster, More Efficient Searches

EVID AI is the only healthcare literature database that uses machine learning to produce more than 80 million data points ─ from pre-clinical, clinical, economic, epidemiology, patient reported outcomes and review focus areas ─ and allows users to filter search results to only the most relevant, current information needed for further analysis.

Curebase, Checkable Medical Announce Joint Clinical Trial to Assess Effectiveness of At-home Strep Test Kit

Curebase, Checkable Medical Announce Joint Clinical Trial to Assess Effectiveness of At-home Strep Test Kit

BOC Sciences Optimizes Production and Development of Microbial Metabolites

CD Formulation Unveils Hygroscopicity Evaluation for Drug Formulation

Open Health Network Launches PatientSphere 2.0 for Cardiology

Open Health Network (OHN) announces the launch of PatientSphere 2.0 for Cardiology, an online system that connects a team of diverse providers to tightly coordinate care for patients with chronic heart conditions. The system offers an evidence-based approach to the real-time integration of every aspect of chronic cardiology care, delivering improved patient outcomes and reducing complexity costs. PatientSphere 2.0 for Cardiology incorporates all the capabilities of its predecessors, PatientSphere and Constant Care. The system also can be modified to support research, clinical and prevention applications in many other indications, both common and rare diseases, including cancer, gastrointestinal disease, diabetes, asthma and sickle cell disease.

STEMart Launches Medical Device Irritation Testing Service

STEMart launches medical device irritation testing service following the biocompatibility guidelines modified for medical devices.

Amerigo Scientific Launches PNGase F for Glycan Release

Amerigo Scientific introduces PNGase F for life science researchers.

Verana Health Launches Population Health Data Engine to Accelerate Clinical Research, Advance Medical Care, and Improve Patient Outcomes

Verana Health Launches Population Health Data Engine to Accelerate Clinical Research, Advance Medical Care, and Improve Patient Outcomes

Torx Software completes release of Torx™, a single web-based platform that will streamline small molecule discovery chemistry

Torx Software Limited announces the release of Torx Test™ and Torx Analyze™ to complete the Torx platform for small molecule discovery chemistry.

Global PharmaceuticalCompany proves validity of AI in life sciences through Pangaea Data’s novel Natural Language Generation driven product

Leading global pharmaceutical company presented Pangaea Data’s Novel AI to Automatically Generate Textual Clinical Narratives for Regulatory Reports

Firstsource and Eco-Mail Partner to Strengthen Workflow Digitization for Health Plans Amidst Permanent Shift to a Remote Workforce

VisualDx Announces Additions to Executive Team to Meet Demand to Improve Health Outcomes

Certara’s Simcyp™ COVID-19 Vaccine Model Wins R&D 100 Award

Biosimulation tool to conduct ‘what-if’ scenarios with virtual patients recognized in Software/Services category

The MALDI-Imaging Lipidomics Service Is Now Available Through Lipidomics Platform

eClinicalWorks Creates a Centralized Platform and Drives Patient Engagement for 50+ Providers at Soma Medical Center, P.A.

Rho’s Chief Medical Officer Jack Modell Presenting During 12th Annual CNS Summit

Rho, a full-service contract research organization (CRO), is showcasing its clinical development expertise during the 12th Annual CNS Summit, taking place at the Encore Boston Harbor Hotel from November 7-10, 2021. Rho’s Chief Medical Officer, Dr. Jack Modell, along with Dr. John Greist and Dr. Thomas Laughren, will present during a Spotlight Session at the Summit. The 50-minute breakout session, titled, “The Seven Essentials of Clinical Development: How to Avoid Shooting Yourself in the Foot” will showcase the speakers’ combined experience in clinical medicine, academic research, regulatory affairs, and development of drugs and medical applications of information technology.

Creative Biostructure Enlarged Its Protein Crystallization Kits Offerings

CD ComputaBio Announces 3D-QSAR Service for Drug Design and Screening

CD ComputaBio, a reliable computational biology service provider located in New York, is always hammering at research and trials in order to provide customers with access to the latest software, technologies, and expertise at a competitive price and fast turnaround time. The company has recently launched 3D-QSAR services for scientists to accelerate the drug development process.

Antibiotic Research UK’s annual lecture calls for global governments to transform funding of new antibiotic sales to prevent another health emergency

The UK’s first charity focused on antibiotic resistance, Antibiotic Research UK (ANTRUK), hosted its annual lecture in London on Thursday 21st October to bring together experts in research, health economics and politics.